Lista de obras - Nicolas Janus - Dominio Público Uruguay

Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients

scientific article published on 15 April 2014

Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.

artículo científico publicado en 2013

Anticancer Drugs in End-Stage Kidney Disease Patients

scientific article published on 11 April 2015

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?

artículo científico publicado en 2020

Cancer and renal insufficiency results of the BIRMA study.

artículo científico publicado en 2010

Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma

artículo científico publicado en 2009

Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study

artículo científico publicado en 2011

Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study

artículo científico publicado en 2014

Letter. Systemic anticancer therapy in gynecological cancer patients with renal dysfunction

artículo científico publicado en 2007

Lung cancer and renal insufficiency: prevalence and anticancer drug issues.

artículo científico publicado en 2008

Malaria prophylaxis in patients with renal impairment: a review

artículo científico publicado en 2013

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study

artículo científico publicado en 2012

New therapies for hepatitis C: considerations in patients with renal impairment.

artículo científico publicado en 2014

Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure

scientific article published on 24 June 2006

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

artículo científico publicado en 2007

Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.

artículo científico publicado en 2014

Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients.

artículo científico publicado en 2010

Pulmonary hypertension: use of oral drugs in patients with renal insufficiency

artículo científico publicado en 2013

Recurrent chimeric fusion RNAs in non-cancer tissues and cells.

artículo científico publicado en 2016

Renal function and venous thromboembolic diseases.

artículo científico publicado en 2016

Renal insufficiency and cancer treatments

artículo científico publicado en 2016

Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study.

artículo científico publicado en 2014

Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria

artículo científico publicado en 2015

Results from the LIDO anemia survey: adherence to EORTC guidelines in cancer patients in France

artículo científico publicado en 2016

Vaccination and chronic kidney disease

artículo científico publicado en 2007

[Anticancer drugs management in renal insufficiency patients]

artículo científico publicado en 2012

[Drug dosage adjustment in patients with renal impairment and evaluation of renal function: focus on the cardiologic patients]

artículo científico publicado en 2014

[How to adjust the dose of drugs in chronic kidney disease?]

scientific article published on 01 March 2012

[Letter on the article: "Kidney and HIV infection"]

artículo científico publicado en 2012

[Management of analgesics in cancer patients with renal impairment]

scientific article published on 01 March 2012

[Management of chemotherapy in hemodialysis patients]

scientific article published on 01 March 2012

[Management of targeted therapies in hemodialysis patients].

artículo científico publicado en 2012

[Renal insufficiency and breast cancer]

artículo científico publicado en 2012

[Renal tolerance of targeted therapies]

artículo científico publicado en 2012

[Renovascular effects of antiangiogenic drugs].

artículo científico publicado en 2016

[Reply to the article Non-VKA oral anticoagulants: an update for the clinical biologists]

artículo científico publicado en 2015

[aMDRD formula is the method of choice for estimating the glomerular filtration rate, even in the "very old": comment on the article by Andro et al]

artículo científico publicado en 2011

Lista de obras de Nicolas Janus

Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients

Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.

Anticancer Drugs in End-Stage Kidney Disease Patients

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?

Cancer and renal insufficiency results of the BIRMA study.

Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma

Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study

Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study

Letter. Systemic anticancer therapy in gynecological cancer patients with renal dysfunction

Lung cancer and renal insufficiency: prevalence and anticancer drug issues.

Malaria prophylaxis in patients with renal impairment: a review

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study

New therapies for hepatitis C: considerations in patients with renal impairment.

Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.

Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients.

Pulmonary hypertension: use of oral drugs in patients with renal insufficiency

Recurrent chimeric fusion RNAs in non-cancer tissues and cells.

Renal function and venous thromboembolic diseases.

Renal insufficiency and cancer treatments

Renal insufficiency, mortality, and drug management in heart transplant. Results of the CARIN study.

Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria

Results from the LIDO anemia survey: adherence to EORTC guidelines in cancer patients in France

Vaccination and chronic kidney disease

[Anticancer drugs management in renal insufficiency patients]

[Drug dosage adjustment in patients with renal impairment and evaluation of renal function: focus on the cardiologic patients]

[How to adjust the dose of drugs in chronic kidney disease?]

[Letter on the article: "Kidney and HIV infection"]

[Management of analgesics in cancer patients with renal impairment]

[Management of chemotherapy in hemodialysis patients]

[Management of targeted therapies in hemodialysis patients].

[Renal insufficiency and breast cancer]

[Renal tolerance of targeted therapies]

[Renovascular effects of antiangiogenic drugs].

[Reply to the article Non-VKA oral anticoagulants: an update for the clinical biologists]

[aMDRD formula is the method of choice for estimating the glomerular filtration rate, even in the "very old": comment on the article by Andro et al]